National Reference Laboratory, the largest network of laboratories in the Middle East accredited by the College of American Pathologists (CAP), is demonstrating its commitment to increasing knowledge and awareness of high-quality laboratory processes and methodologies among healthcare professionals in the region by leading and participating in key educational events in 2018, including Arab Health and MEDLAB.
Abu Dhabi - National Reference Laboratory (NRL), part of Mubadala Investment Company, will continue its successful delivery of educational seminars for laboratory professionals and other healthcare practitioners at two of the largest upcoming healthcare events in the region – Arab Health and MEDLAB. During MEDLAB, taking place in Dubai from February 5-8, a number of NRL’s laboratory experts will present eight lectures on the development of laboratory services to improve standards of care and patient outcomes in the UAE and regionally. NRL will also lead two workshops: one focused on genetic testing; and, one focused on laboratory accreditation and international quality assurance standards.
“In line with our strategic commitment to bring advanced laboratory testing to the region, with the support of our USA partner LabCorp®, we have invested significantly to further increase our in-country specialized testing capacity by establishing multiple centers of excellence. In this respect, MEDLAB and Arab Health provide excellent forums for our experts to share their scientific knowledge and to increase awareness of the high-quality diagnostic testing now available to patients through NRL laboratories,” said Abdul Hamid Oubeisi, CEO of NRL.
Dr. Basel Altrabulsi, Chief Medical Officer of NRL, commented: “NRL has become the largest network of laboratories in the Middle East accredited by the College of American Pathologists (CAP) because we strongly believe in the importance of accreditation and international standards in medical laboratory services. During 2017, we hosted a successful CAP Inspectors Training Workshop and a number of other educational sessions on a variety of laboratory medicine subjects as part of our mission to educate healthcare professionals and raise awareness. We also contributed to the scientific program of numerous conferences. We look forward to delivering an even more ambitious plan of educational activities in 2018, starting with our Laboratory Accreditation Workshop and our Genetics Workshop at MEDLAB.”
Presentations of NRL Experts at MEDLAB
The Role of Quality Assurance Programs in Optimizing Laboratory Cost-Management
Faisal Ibrahim, Director - Quality Assurance, NRL
5th February, 10:00 – 10:30, Track: Laboratory Management
Glycated Albumin: More than a Biomarker of Glycemic Control
Dr. Shereen Atef, Consultant Clinical Pathologist, NRL
5th February, 11:30 – 12:00, Track: Lab Testing and Management of Diabetes
Molecular Classification of Endometrial Cancers
Dr. Basel Altrabulsi, Chief Medical Officer, NRL
6th February, 12:30- 13:00, Track: Obs-Gyne Oncology
Laboratory Dashboards and Performance Management
Gagan Goel, IT Director, NRL
6th February, 11:30 – 12:00, Track: Laboratory Informatics
Pre-analytical Challenges & Advanced Coagulation Testing
Dr. Jay Murthy, Technical Director, NRL
6th February, 14:45 – 15:30, Track: Haematology
Liquid Biopsy – Introduction and Overview
Dr. Basel Altrabulsi, Chief Medical Officer, NRL
7th February, 12:30 – 13:00, Track: Tumor Markets
Revolution in Bacterial Identification and Microbiology Efficiencies – MALDI-TOF
Albarah El Khani, Director - Technical Operations, NRL
7th February, 17:00 – 17:30, Track: Clinical Microbiology
Challenges in the Interpretation of Radiologically Detected Breast Lesions
Dr. Suhaila Alameeri, Consultant Anatomic Pathologist, NRL
8th February, 14:00 – 14:20, Track: Histopathology
NRL Workshops at MEDLAB
Genetics Workshop
6th February, 14:00 – 17:30
Hereditary Cancers Screening
Dr. Clay Gipson, Ph.D, Vice President, LabCorp/ Integrated Oncology (USA)
The Role of Genetic Counseling in the Era of Personalized Genetic Medicine
Rifaat Rawashdeh, MS, CGC, Genetic Counselor, National Reference Laboratory (UAE)
Genetic Testing in a Post Genome World: A User’s Guide
Dr. Marshall Summar, Director, Rare Disease Institute, Children’s National Health System (USA)
Laboratory Accreditation Workshop
7th February, 13:30 – 17:00
Globally Recognized Standards and the Medical Laboratory
Patrick Mateta, Vice President, CLSI Global Health Partnership, USA
The Role of the National Accreditation System in the UAE Healthcare
Dr. Rehab Al Ameri, Director, Emirates National Accreditation System, UAE
Pre-analytical Quality Improvement
Dr. Bruce William, President, The College of American Pathologists, USA
Test Method Validation
Faisal Ibrahim, MBA, MT (ASCP), Director - Quality Assurance, National Reference Laboratory, UAE
Blood and Urine Contamination Rates
Dr. Elizabeth Wagar, Medical Director, The University of Texas, MD Anderson Cancer Center, USA
Arab Health will run from January 29 to February 1, 2018, in the Dubai International Convention and Exhibition Center, Dubai, UAE. For more information please visit: www.arabhealthonline.com
MEDLAB will run from February 5-8, 2018, in the Dubai International Convention and Exhibition Center, Dubai, UAE. For more information please visit: http://www.medlabme.com
-Ends-
About National Reference Laboratory
National Reference Laboratory (NRL) is a Mubadala Investment Company, created in partnership with and managed by LabCorp, a leading global life sciences company providing comprehensive clinical laboratory services. NRL’s vision is to increase the spectrum, coverage and overall efficiency of laboratory testing, to implement international best practice reference laboratory processes and to set the benchmark for quality standards in the region.
Together with the significant resources of LabCorp, NRL offers a comprehensive menu of more than 4,700 tests, providing a complete solution for all clinical testing needs in an efficient and high-quality environment that reduces both turnaround time and logistics-related costs, compared with other laboratories. The diverse and growing network of NRL currently includes ten owned and managed laboratories across the UAE. For more information, please visit www.nrl.ae.
About LabCorp:
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion for 2016. To learn more about LabCorp, visit www.labcorp.com, and to learn more about Covance Drug Development, visit www.covance.com.
